Scientists investigated the effect of CDK-Rb pathway blockade on isocitrate dehydrogenase (IDH)-mutant glioma growth in vitro and in vivo using CDK4/6 inhibitors.
[Clinical Cancer Research]
Home Newsletters Neural Cell News CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition
